Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles
Open Access
- 1 June 2018
- journal article
- review article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (6) , 630-645
Abstract
No abstract availableKeywords
Funding Information
- Besins Healthcare (UK) Ltd.
This publication has 37 references indexed in Scilit:
- Luteal phase support in intrauterine insemination cycles: a prospective randomized study of 300 mg versus 600 mg intravaginal progesterone tabletGynecological Endocrinology, 2015
- Timing luteal support in assisted reproductive technology: a systematic reviewFertility and Sterility, 2015
- Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase supportReproductive Health, 2014
- A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injectionHuman Reproduction, 2012
- Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulationFertility and Sterility, 2009
- Luteal phase support in assisted reproduction cyclesCochrane Database of Systematic Reviews, 2008
- Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeksHuman Reproduction, 2008
- Maternal Progestin Intake and Risk of HypospadiasArchives of Pediatrics & Adolescent Medicine, 2005
- Luteal phase support in assisted reproduction cycles2004
- Effects of Vaginal Progesterone Administration Starting on the Day of Oocyte Retrieval on Pregnancy RatesJournal of Assisted Reproduction and Genetics, 2003